<DOC>
	<DOCNO>NCT00579189</DOCNO>
	<brief_summary>The purpose study determine topical otic formulation safe effective treat middle ear infection patient ear tube .</brief_summary>
	<brief_title>Phase III Study Otic Formulation Acute Otitis Media With Tympanostomy Tubes</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>6 month 12 year old Ear tube one ear Ear drainage visible parent / guardian Ear drainage le 21 day Ear tube may silver oxide , silver salt , ttype tube longshafted tube Patient may nontube otorrhea Patient may otic surgery tube placement last year Patient may menarchal female Diabetic patient eligible Patient may disease condition would negatively affect conduct study Patient may require systemic antimicrobial therapy study . Patient must meet certain medication washout eligible Analgesic use ( acetaminophen ) allow Patient may predispose neurosensory hearing loss Other protocoldefined inclusion criterion may apply Age Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ear tube</keyword>
	<keyword>ear drainage</keyword>
	<keyword>ear infection</keyword>
	<keyword>ear drop</keyword>
</DOC>